Format

Send to

Choose Destination
Eur J Med Chem. 2010 Nov;45(11):5140-9. doi: 10.1016/j.ejmech.2010.08.026. Epub 2010 Aug 14.

Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylase.

Author information

1
Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Avda. del Conocimiento s/n, 18100-Armilla, Granada, Spain.

Abstract

Plasmodium falciparum purine nucleoside phosphorylase (PfPNP) has a central role in purine salvage and inhibitors of the enzyme have been shown to have antiplasmodial activity. The enzyme preferentially uses inosine as substrate (K(m)=5 μM, k(cat)/K(m)=7.4×10(4) M(-1) s(-1)), but can also use uridine, albeit less efficiently (K(m)=85 μM, k(cat)/K(m)=306 M(-1) s(-1)). In an effort to identify new PfPNP inhibitors, two series of compounds were prepared. Series 1 was based on known human uridine phosphorylase inhibitors whilst series 2 was uracil equivalents of purine-based PNP transition state inhibitors. These two series of compounds were assayed for inhibition of both PfPNP activity and growth of P. falciparum. The transition state analogues were found to be moderate inhibitors of PfPNP (most potent compound, K(i)=6 μM).

PMID:
20817362
DOI:
10.1016/j.ejmech.2010.08.026
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center